clinical reporting
The Importance of Simulation and Modelling in Clinical Trial Design
February 18 by Pharmaceuticals & Biotechnology EditorOncology Market Leaders Must Look to Clinical Development for Future Growth
November 17 by Pharma IQOver recent years cancer drugs have moved from the traditional chemotherapies, which provided significant side effects, to more targeted therapies. However, according to a recent Reuters rep...
Adaptive and Group Sequential Clinical Methods for Clinical Trial Design
November 11 by Pharma IQChris Jennison, Professor of Statistics at the University of Bath, talks to Helen Winsor from Pharma IQ, about adaptive and group sequential clinical methods for clinical trial design and how i...
Is Adaptive Design just a Buzzword Solution?
November 09 by Helen WinsorChris Jennison, Professor of Statistics at the University of Bath, joins Pharma IQ to discuss the merits of Sequential Monitoring and Adaptive Design. Pharma IQ: Chris, welcome, I’m pleased...
Where is Health Technology Assessment Going?
November 04 by Pharma IQChrissie Fletcher, Director and Head of International Biostatistics at Amgen, talks to Helen Winsor from Pharma IQ, about innovation in clinical design, analysis and reporting. Fletcher disc...
Getting a Handle on PK Parameters
October 19 by Helen WinsorThomas Jaki, lecturer at Lancaster University and an expert in the estimation of PK parameters, joins Pharma IQ to discuss the challenges and changes in this area. Pharma IQ: Thomas, welcome. So,...
Bringing Innovation to Clinical Design
September 28 by Pharma IQClinical trials may be one of the most fundamental parts of drug development work carried out in the pharmaceutical industry, but they still remain a complicated area for pharma companies to address....
Adaptive Design, Often Maligned
September 22 by Pharma IQWhen carried out well, adaptive trials not only provide evidence of safety and efficacy more quickly, but also allow you to assess that evidence and get answers earlier. In this inter...
